Advances in immunotherapy for COVID-19: A comprehensive review
M Masoomikarimi, B Garmabi, J Alizadeh… - International …, 2021 - Elsevier
COVID-19 is an acute respiratory syndrome caused by SARS-COV-2 which has now
become a huge pandemic worldwide. The immunopathogenesis of COVID-19 has been …
become a huge pandemic worldwide. The immunopathogenesis of COVID-19 has been …
The immune system as a target for therapy of SARS-CoV-2: a systematic review of the current immunotherapies for COVID-19
AH Mansourabadi, M Sadeghalvad… - Life sciences, 2020 - Elsevier
Aims The immune response is essential for the control and resolution of viral infections.
Following the outbreak of novel coronavirus disease (COVID-19), several immunotherapies …
Following the outbreak of novel coronavirus disease (COVID-19), several immunotherapies …
The immunology and immunotherapy for COVID-19
Y Liu, X Zhou, X Liu, X Jiang - Expert reviews in molecular medicine, 2021 - cambridge.org
The ongoing global pandemic of coronavirus disease 2019 (COVID-19) is caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and significantly impacts the world …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and significantly impacts the world …
Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments
P Goodarzi, F Mahdavi, R Mirzaei, H Hasanvand… - International …, 2020 - Elsevier
The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …
The possible of immunotherapy for COVID-19: A systematic review
A AminJafari, S Ghasemi - International Immunopharmacology, 2020 - Elsevier
Abstract The novel coronavirus (2019-nCoV) is an emerging pathogen that was first
described in late December 2019 and causes a severe respiratory infection in humans …
described in late December 2019 and causes a severe respiratory infection in humans …
[HTML][HTML] Immune-based therapeutic approaches in COVID-19
Abstract Coronavirus disease 2019 (COVID-19) is a viral disease caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), a member of the Coronaviridae family …
respiratory syndrome coronavirus-2 (SARS-CoV-2), a member of the Coronaviridae family …
An overview of some potential immunotherapeutic options against COVID-19
M Bayat, Y Asemani, MR Mohammadi, M Sanaei… - International …, 2021 - Elsevier
After the advent of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …
COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches
M Zavvar, A Yahyapoor, H Baghdadi… - International …, 2022 - Elsevier
Multiple efforts are currently underway to control and treat severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19) …
syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19) …
Immunotherapy for SARS-CoV-2: potential opportunities
M Pashaei, N Rezaei - Expert opinion on biological therapy, 2020 - Taylor & Francis
Coronavirus Disease 2019 (COVID-19), caused by a novel coronavirus, called Severe Acute
Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), emerged at the end of 2019 in Wuhan …
Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), emerged at the end of 2019 in Wuhan …
Immunobiology and immunotherapy of COVID‐19: A clinically updated overview
A Esmaeilzadeh, R Elahi - Journal of cellular physiology, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a new member of the
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …